SCHEMBL6132402

SCHEMBL6132402

COC(=O)c1ccc(C(=O)NNC(=O)c2ccc(N3CCC(OC)(C4CCCCC4)CC3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
HDAC3 O15379 5/20 0.44
HDAC8 Q9BY41 5/20 0.44
MAPT P10636 4/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 2/20 0.40
NR4A1 P22736 1/20 0.40
MCL1 Q07820 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 1/20 0.39
NPC1 O15118 1/20 0.39
EPHX2 P34913 1/20 0.39
SMYD3 Q9H7B4 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6379350 0.99 ALDH1A1 (0.47) ALDH1A1HDAC3HDAC8MAPTKMT2A
SCHEMBL13099125 0.94 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ARAB9AMEN1
SCHEMBL6373882 0.90 USP2 (0.47) ALDH1A1HDAC3HDAC8MAPTKMT2A
SCHEMBL6132324 0.86 HDAC3 (0.43) ALDH1A1HDAC3HDAC8MAPTKMT2A
SCHEMBL13098789 0.86 ALDH1A1 (0.45) ALDH1A1HDAC3HDAC8MAPTKMT2A
SCHEMBL6374849 0.85 HDAC3 (0.44) ALDH1A1HDAC3HDAC8MAPTKMT2A
SCHEMBL13273660 0.83 MAPT (0.49) ALDH1A1MAPTKMT2ARAB9AMEN1
SCHEMBL13099171 0.83 USP2 (0.52) ALDH1A1MAPTKMT2ARAB9AMEN1
SCHEMBL6132560 0.83 PDE4D (0.48) ALDH1A1MAPTKMT2ARAB9AMEN1
SCHEMBL6132697 0.83 SIRT2 (0.45) ALDH1A1KMT2ARAB9AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884774-B2 Cyclic hexapeptide derivatives FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-04-26 US disclosed
US-20030083238-A1 Cyclic hexapeptide derivatives ASTELLAS PHARMA INC. (JP) 2003-05-01 US disclosed
EP-1259535-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP disclosed
WO-2001060846-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083238-A1 Cyclic hexapeptide derivatives NGLY1, ALG1, CHIT1 ALDH1A1 4718/4885HDAC3 1534/4885HDAC8 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.